- Home
- PMCB vs GV Comparison
PMCB vs GV Comparison
Compare PMCB & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- GV
- Stock Information
- Founded
- PMCB 1996
- GV 2013
- Country
- PMCB United States
- GV Canada
- Employees
- PMCB 2
- GV N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- GV Other Consumer Services
- Sector
- PMCB Health Care
- GV Real Estate
- Exchange
- PMCB Nasdaq
- GV Nasdaq
- Market Cap
- PMCB 11.4M
- GV 5.8M
- IPO Year
- PMCB N/A
- GV 2022
- Fundamental
- Price
- PMCB $1.64
- GV $1.47
- Analyst Decision
- PMCB
- GV
- Analyst Count
- PMCB 0
- GV 0
- Target Price
- PMCB N/A
- GV N/A
- AVG Volume (30 Days)
- PMCB 14.0K
- GV 384.5K
- Earning Date
- PMCB 12-24-2024
- GV 12-31-2024
- Dividend Yield
- PMCB N/A
- GV N/A
- EPS Growth
- PMCB N/A
- GV N/A
- EPS
- PMCB 0.74
- GV 0.32
- Revenue
- PMCB N/A
- GV $9,380,985.00
- Revenue This Year
- PMCB N/A
- GV N/A
- Revenue Next Year
- PMCB N/A
- GV N/A
- P/E Ratio
- PMCB $2.21
- GV $4.86
- Revenue Growth
- PMCB N/A
- GV 11.25
- 52 Week Low
- PMCB $1.39
- GV $1.00
- 52 Week High
- PMCB $2.58
- GV $8.85
- Technical
- Relative Strength Index (RSI)
- PMCB 45.24
- GV 45.74
- Support Level
- PMCB $1.60
- GV $1.25
- Resistance Level
- PMCB $1.69
- GV $3.01
- Average True Range (ATR)
- PMCB 0.11
- GV 0.31
- MACD
- PMCB -0.00
- GV 0.02
- Stochastic Oscillator
- PMCB 40.00
- GV 5.11
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.